These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Use of Anovlar in gynaecological disorders and contraception. Shahani SM; Chiklikar A J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827 [TBL] [Abstract][Full Text] [Related]
14. [ORAL CONTRACEPTION: PHYSIOLOGY AND A PRELIMINARY ACCOUNT OF OUR OWN CLINICAL MATERIAL]. LARSSON-COHN U Sven Lakartidn; 1964 Apr; 61():1328-48. PubMed ID: 14148470 [No Abstract] [Full Text] [Related]
16. [ORAL CONTRACEPTION IN THE CYTOLOGICAL AND MICROBIOLOGICAL PICTURE OF THE VAGINA]. ZIZKOVA A Cesk Gynekol; 1964 Feb; 29():20-3. PubMed ID: 14142655 [No Abstract] [Full Text] [Related]
17. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users. Zaki K; Sami G; Nour H Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026 [TBL] [Abstract][Full Text] [Related]
18. "Anovlar" as an oral contraceptive. MEARS E; GRANT EC Br Med J; 1962 Jul; 2(5297):75-9. PubMed ID: 14471933 [No Abstract] [Full Text] [Related]
19. ORAL CONTRACEPTIVES AND LIVER DAMAGE. CARLSTROEM H; HOEGLUND S; REIZENSTEIN P Br Med J; 1965 Apr; 1(5440):993. PubMed ID: 14260636 [No Abstract] [Full Text] [Related]